Giorgia Gurioli

10PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 19, 2026
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Milena Urbini, Thomas F Eleveld, Maurizio Polano

|Oct 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer.

Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas

|Dec 09, 2023
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors.

Milena Urbini, Sara Bleve, Giuseppe Schepisi

|Jan 21, 2023
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma.

Domenico D'Arca, Leda Severi, Stefania Ferrari

|Dec 23, 2022
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.

Giorgia Gurioli, Gianluca Tedaldi, Alberto Farolfi

|May 14, 2022
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.

Vincenza Conteduca, Chiara Casadei, Emanuela Scarpi

Pageof 2

Frequent Collaborators

9 joint publications

Ugo De Giorgi

6 joint publications

Giuseppe Schepisi

4 joint publications

Vincenza Conteduca

4 joint publications

Milena Urbini